Problems in the digestive system reveal how tiny plastics may worsen Parkinson’s disease metabolism

Oral polystyrene nanoplastics may aggravate Parkinson's-related pathology by disrupting the gut-liver axis and metabolism.

A preclinical A53T alpha-synuclein mouse experiment dosed PS nanoplastics orally at 2 mg/kg every other day for three months and measured ileal barrier injury, a 30% goblet-cell drop, Desulfovibrio overgrowth, pathway changes, more than 200 altered fecal metabolites, and liver inflammation.

The findings come from a transgenic mouse exposure model with omics and histology endpoints, so relevance to human environmental exposure and Parkinson's progression remains uncertain.